Ritratto di clemens.zwergel@uniroma1.it

Per gli studenti della laurea magistrale in "Chimica e tecnologia farmaceutiche (sede di Latina)" le lezioni di "Analisi Chimico Farmaceutica e Tossicologica II" inizieranno l'11. ottobre 2023 alle 11:00 presso l'aula 8 della sede di Corso della Repubblica.Tutti i dettagli relativi al corso, all'esame e al relativo materiale didattico saranno illustrati durante la prima lezione.

 

 

Ricevimento studenti: Attualmente il ricevimento è per appuntamento concordato tramite e-mail.

 

Consulting hours for students: please write an email for an appointment.

Insegnamento Codice Anno Corso - Frequentare Bacheca
PRINCIPLE OF MEDICINAL CHEMISTRY 10602997 2023/2024
ANALISI CHIMICO FARMACEUTICA E TOSSICOLOGICA II 1022762 2023/2024
ANALISI CHIMICO FARMACEUTICA E TOSSICOLOGICA II 1022762 2023/2024
ANALISI CHIMICO FARMACEUTICA E TOSSICOLOGICA II 1022762 2022/2023
FUNDAMENTALS OF CHEMICAL BIOLOGY 10607290 2022/2023
MARKETING E TECNICHE DI ACCESSO AL MERCATO FARMACEUTICO 1052178 2021/2022
LABORATORIO DI ESTRAZIONE DI COMPOSTI NATURALI - ANALISI DEI PRINCIPI ATTIVI DELLE PIANTE MEDICINALI E AROMATICHE 1052186 2020/2021

previo appuntamento tramite mail: clemens.zwergel@uniroma1.it

Dr. Clemens Zwergel is currently an Assistant Professor (RTD-A) at the Sapienza University of Rome. In the last years he proved to be a true European citizen: he moved after his license to practise as Pharmacist from his country of origin (Germany) to Exter (UK) for a Diploma in Pharmaceutical Sciences. Before moving to Italy, he was then a MarieCurie fellow in France (Metz) where he obtained his EuroPhD within the RedCat network. Since 2010, his main research interest lies mainly in the design and synthesis of analogues of natural compounds as well as modulators of epigenetic enzymes with potential applications in cancer, neurodegenerative, metabolic, and infectious diseases resulting in more than 65 publications (https://www.scopus.com/authid/detail.uri?authorId=37017859900). Communication and divulging science are very important aspects for a researcher, thus I would like to increase the visibility of Medicinal Chemistry and the EFMC to the scientific community as well as the general public as well as strengthen the European collaborations together with the other team members.